Your browser doesn't support javascript.
loading
A human importin-ß-related disorder: Syndromic thoracic aortic aneurysm caused by bi-allelic loss-of-function variants in IPO8.
Van Gucht, Ilse; Meester, Josephina A N; Bento, Jotte Rodrigues; Bastiaansen, Maaike; Bastianen, Jarl; Luyckx, Ilse; Van Den Heuvel, Lotte; Neutel, Cédric H G; Guns, Pieter-Jan; Vermont, Mandy; Fransen, Erik; Perik, Melanie H A M; Velchev, Joe Davis; Alaerts, Maaike; Schepers, Dorien; Peeters, Silke; Pintelon, Isabel; Almesned, Abdulrahman; Ferla, Matteo P; Taylor, Jenny C; Dallosso, Anthony R; Williams, Maggie; Evans, Julie; Rosenfeld, Jill A; Sluysmans, Thierry; Rodrigues, Desiderio; Chikermane, Ashish; Bharmappanavara, Gangadhara; Vijayakumar, Kayal; Mottaghi Moghaddam Shahri, Hassan; Hashemi, Narges; Torbati, Paria Najarzadeh; Toosi, Mehran B; Al-Hassnan, Zuhair N; Vogt, Julie; Revencu, Nicole; Maystadt, Isabelle; Miller, Erin M; Weaver, K Nicole; Begtrup, Amber; Houlden, Henry; Murphy, David; Maroofian, Reza; Pagnamenta, Alistair T; Van Laer, Lut; Loeys, Bart L; Verstraeten, Aline.
Affiliation
  • Van Gucht I; Center of Medical Genetics, University of Antwerp and Antwerp University Hospital, Edegem 2650, Belgium.
  • Meester JAN; Center of Medical Genetics, University of Antwerp and Antwerp University Hospital, Edegem 2650, Belgium.
  • Bento JR; Center of Medical Genetics, University of Antwerp and Antwerp University Hospital, Edegem 2650, Belgium.
  • Bastiaansen M; Center of Medical Genetics, University of Antwerp and Antwerp University Hospital, Edegem 2650, Belgium.
  • Bastianen J; Center of Medical Genetics, University of Antwerp and Antwerp University Hospital, Edegem 2650, Belgium.
  • Luyckx I; Center of Medical Genetics, University of Antwerp and Antwerp University Hospital, Edegem 2650, Belgium; Department of Human Genetics, Radboud University Nijmegen Medical Center, Nijmegen 6525 GA, the Netherlands.
  • Van Den Heuvel L; Center of Medical Genetics, University of Antwerp and Antwerp University Hospital, Edegem 2650, Belgium.
  • Neutel CHG; Laboratory of Physiopharmacology, University of Antwerp, Antwerp 2610, Belgium.
  • Guns PJ; Laboratory of Physiopharmacology, University of Antwerp, Antwerp 2610, Belgium.
  • Vermont M; Laboratory of Physiopharmacology, University of Antwerp, Antwerp 2610, Belgium.
  • Fransen E; Center of Medical Genetics, University of Antwerp and Antwerp University Hospital, Edegem 2650, Belgium; StatUa Center for Statistics, University of Antwerp, Antwerp 2000, Belgium.
  • Perik MHAM; Center of Medical Genetics, University of Antwerp and Antwerp University Hospital, Edegem 2650, Belgium.
  • Velchev JD; Center of Medical Genetics, University of Antwerp and Antwerp University Hospital, Edegem 2650, Belgium.
  • Alaerts M; Center of Medical Genetics, University of Antwerp and Antwerp University Hospital, Edegem 2650, Belgium.
  • Schepers D; Center of Medical Genetics, University of Antwerp and Antwerp University Hospital, Edegem 2650, Belgium; Laboratory of Molecular, Cellular and Network Excitability, Department of Biomedical Sciences, University of Antwerp, Antwerp 2610, Belgium.
  • Peeters S; Center of Medical Genetics, University of Antwerp and Antwerp University Hospital, Edegem 2650, Belgium.
  • Pintelon I; Laboratory of Cell Biology & Histology, Department of Veterinary Sciences, University of Antwerp, Antwerp 2610, Belgium.
  • Almesned A; Prince Sultan Cardiac Centre, Qassim 31982, Saudi Arabia.
  • Ferla MP; NIHR Oxford Biomedical Research Centre, Wellcome Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK.
  • Taylor JC; NIHR Oxford Biomedical Research Centre, Wellcome Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK.
  • Dallosso AR; Bristol Genetics Laboratory, South West Genomic Laboratory Hub, Southmead Hospital, Bristol BS10 5NB, UK.
  • Williams M; Bristol Genetics Laboratory, South West Genomic Laboratory Hub, Southmead Hospital, Bristol BS10 5NB, UK.
  • Evans J; Bristol Genetics Laboratory, South West Genomic Laboratory Hub, Southmead Hospital, Bristol BS10 5NB, UK.
  • Rosenfeld JA; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA; Baylor Genetics Laboratories, Houston, TX 77021, USA.
  • Sluysmans T; Department of Pediatric Cardiology, Cliniques Universitaires Saint-Luc, University of Louvain, Brussels 1200, Belgium.
  • Rodrigues D; Birmingham Women's and Children's Hospital NHS Foundation Trust, Steelhouse Lane, Birmingham B4 6NH, UK.
  • Chikermane A; Birmingham Women & Children's Hospital, Birmingham B4 6NH, UK.
  • Bharmappanavara G; Musgrove Park Hospital, Somerset NHS Foundation Trust, Taunton TA1 5DA, UK.
  • Vijayakumar K; Department of Paediatric Neurology, University Hospitals Bristol NHS Foundation Trust, Bristol BS2 8BJ, UK.
  • Mottaghi Moghaddam Shahri H; Pediatric Department, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad 009851, Iran.
  • Hashemi N; Department of Pediatric Neurology, School of Medicine, Mashhad University of Medical Sciences, Mashhad 009851, Iran.
  • Torbati PN; Department of Molecular Genetics, Next Generation Genetic Polyclinic, Mashhad University of Medical Sciences, Mashhad 009851, Iran.
  • Toosi MB; Department of Pediatric Neurology, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad 009851, Iran.
  • Al-Hassnan ZN; Cardiovascular Genetic Program, Department of Medical Genetics, King Faisal Specialist Hospital and Research Centre, Riyadh 11564, Saudi Arabia.
  • Vogt J; West Midlands Regional Genetics Service, Birmingham Women's and Children's Hospital, Birmingham, B15 2TG, UK.
  • Revencu N; Center for Human Genetics, Cliniques Universitaires Saint-Luc, University of Louvain, Brussels 1200, Belgium.
  • Maystadt I; Centre de Génétique Humaine, Institut de Pathologie et de Génétique, Gosselies (Charleroi) 6041, Belgium.
  • Miller EM; The Heart Institute, Department of Pediatrics, Cincinnati Children's Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA.
  • Weaver KN; Division of Human Genetics, Department of Pediatrics, Cincinnati Children's Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA.
  • Begtrup A; GeneDx, Gaithersburg, MD 20877, USA.
  • Houlden H; Department of Neuromuscular Disorders, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK.
  • Murphy D; Department of Neuromuscular Disorders, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK.
  • Maroofian R; Department of Neuromuscular Disorders, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK.
  • Pagnamenta AT; NIHR Oxford Biomedical Research Centre, Wellcome Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK.
  • Van Laer L; Center of Medical Genetics, University of Antwerp and Antwerp University Hospital, Edegem 2650, Belgium.
  • Loeys BL; Center of Medical Genetics, University of Antwerp and Antwerp University Hospital, Edegem 2650, Belgium; Department of Human Genetics, Radboud University Nijmegen Medical Center, Nijmegen 6525 GA, the Netherlands. Electronic address: bart.loeys@uantwerpen.be.
  • Verstraeten A; Center of Medical Genetics, University of Antwerp and Antwerp University Hospital, Edegem 2650, Belgium. Electronic address: aline.verstraeten@uantwerpen.be.
Am J Hum Genet ; 108(6): 1115-1125, 2021 06 03.
Article in En | MEDLINE | ID: mdl-34010605
ABSTRACT
Importin 8, encoded by IPO8, is a ubiquitously expressed member of the importinprotein family that translocates cargo molecules such as proteins, RNAs, and ribonucleoprotein complexes into the nucleus in a RanGTP-dependent manner. Current knowledge of the cargoes of importin 8 is limited, but TGF-ß signaling components such as SMAD1-4 have been suggested to be among them. Here, we report that bi-allelic loss-of-function variants in IPO8 cause a syndromic form of thoracic aortic aneurysm (TAA) with clinical overlap with Loeys-Dietz and Shprintzen-Goldberg syndromes. Seven individuals from six unrelated families showed a consistent phenotype with early-onset TAA, motor developmental delay, connective tissue findings, and craniofacial dysmorphic features. A C57BL/6N Ipo8 knockout mouse model recapitulates TAA development from 8-12 weeks onward in both sexes but most prominently shows ascending aorta dilatation with a propensity for dissection in males. Compliance assays suggest augmented passive stiffness of the ascending aorta in male Ipo8-/- mice throughout life. Immunohistological investigation of mutant aortic walls reveals elastic fiber disorganization and fragmentation along with a signature of increased TGF-ß signaling, as evidenced by nuclear pSmad2 accumulation. RT-qPCR assays of the aortic wall in male Ipo8-/- mice demonstrate decreased Smad6/7 and increased Mmp2 and Ccn2 (Ctgf) expression, reinforcing a role for dysregulation of the TGF-ß signaling pathway in TAA development. Because importin 8 is the most downstream TGF-ß-related effector implicated in TAA pathogenesis so far, it offers opportunities for future mechanistic studies and represents a candidate drug target for TAA.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenotype / Aortic Aneurysm, Thoracic / Loss of Heterozygosity / Beta Karyopherins / Loss of Function Mutation Type of study: Prognostic_studies Limits: Adult / Animals / Child / Child, preschool / Female / Humans / Male Language: En Journal: Am J Hum Genet Year: 2021 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenotype / Aortic Aneurysm, Thoracic / Loss of Heterozygosity / Beta Karyopherins / Loss of Function Mutation Type of study: Prognostic_studies Limits: Adult / Animals / Child / Child, preschool / Female / Humans / Male Language: En Journal: Am J Hum Genet Year: 2021 Document type: Article Affiliation country: